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A cytosol protein that specifically binds cholesterol derivatives oxygenated on the side chain has been dem- 
onstrated in rat liver and transformed HTC cells. This protein, of which the sedimentation coefficient is
about 8 S, was saturable and showed ahigh binding affinity (& about 5 x 10m9 M) for 25-hydroxycholester- 
01. Its molecular mass is about 160 kDa. The physicochemical haracteristics of this protein were identical 
whether the model was normal or transformed. This oxysterol-binding protein differs from the well-known 
sterol carrier proteins. 
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1. INTRODUCTION 
Proteins that specifically bind oxysterols 
(OSBPs) have been described in several cell models 
[l--5]. They are thought to play a regulatory role 
in either sterol synthesis [6], or cell proliferation 
[5], or both. 
Purification of the OSBP is now an essential 
step for investigation of its biological role. This 
cannot be performed with cell cultures because of 
the great quantity of biological material needed. 
Rat liver could be a good model for OSBP 
purification since (i) liver is a cholesterogenic 
organ in which OSBP might have a major role in 
the regulation of HMG-CoA reductase activity and 
(ii) preliminary work by Kandutsch and Thompson 
[2] seemed to indicate the presence of an OSBP in 
liver cell cultures. 
The present work shows the presence of a high 
level of OSBP in rat liver cytosol and reports the 
physicochemical characters of this protein. 
Moreover, we compare the properties of normal 
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rat liver and HTC cell OSBPs; HTC cells, derived 
from rat hepatoma, provide a model for studying 
the OSBP in cancerous cells and we demonstrate 
that cancerisation does not alter the properties of 
hepatic OSBP. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
2.1.1. Radioactive compounds 
25-Hydroxy[26,27-3H]cholesterol (87 Ci/mmol) 
(New England Nuclear) was checked for radioac- 
tive purity by thin-layer chromatography (two suc- 
cessive elutions in chloroform-methanol-ethanol, 
80:2: i.5 then 80: 1:0.5, v/v). 
2.1.2. Unlabeled sterols and steroids 
The following products were kindly donated: 
cholest-5-ene-3fl,25-diol [25-hydroxycholesterol] 
from Roussel-Uclaf (Romainville, France); 
cholest-5,20(22)-diene-3,&,25-diol [20(22)-dehydro- 
25-hydroxycholesterol], cholest-5,23-diene-3P,25- 
diol [23-dehydrocholesterol], cholest-5-ene- 
3,&,7,25-trio1 and (22R)-2@,3fl,14,20,22,25_hexa- 
hydroxycholest-7-ene-6-one [20-hydroxyecdysone] 
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from G. Ourisson and Luu Bang (Strasbourg, 
France); cholest-5-ene-3fi,23(S)-diol [23(S)-hy- 
droxycholesterol], cholest-5-ene-3,&,23(R)-diol [23- 
(R)-hydroxycholesterol], cholest-5-ene-3,&,24(R)-diol 
[24(R)-hydroxycholesterol], cholest-5-ene-3fl,24- 
(S)-diol [24(S)-hydroxycholesterol] and cholest-5- 
ene-3P,26(25R)-diol [26-hydroxycholesterol] from 
J.E. Van Lier (Sherbrooke, Canada). The follow- 
ing were of commercial origin: cholest-5-ene-3,&ol 
[cholesterol], 9~-fluoro-l6&methyl-ll,17fl,21-tri- 
hydroxypregna-1,4-diene-3,20-dione [dexametha- 
sone], 1,3,5-estratriene-3,17&diol [estradiol] and 
2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetra- 
cosahexaene [squalene] from Sigma; cholest-5-ene- 
3P,7cu-diol [7cu-hydroxycholesterol], cholest-5-ene- 
3P,7P-diol [7,&hydroxycholesterol], 3&hydroxy- 
cholest-5-ene-7-one [7-ketocholesterol] and cho- 
lest-5-ene-3,0,20cu-diol [20cu-hydroxycholesterol] 
from Steraloids; 1- ( 4-(2-dimethylaminoethoxyl)- 
phenyl ) - 1 - (6hydroxyphenyl) -Z- phenylbut - l(2) - 
ene [hydroxytamoxifen] from ICI. 24(R,S),25- 
Epoxycholesterol was synthesized in the laboratory 
by treating cholest-5,24-diene-3P_ol (desmosterol, 
Steraloids) with chloroperbenzoic acid according 
to [7]; 2,6,10,15,19,23-hexamethyl-2,6,10,14,18, 
22-tetracosahexaene-2&3S-epoxide [oxidosqua- 
lene] and 25-hydroxycholesterol-3P_acetate w re 
synthesized in the laboratory. 
2.1.3. Other materials 
Aprotinin (5000 KIU/ml), PMSF, leupeptin and 
TPCK were from Sigma; Tris from Boehringer; 
EDTA, potassium mono- and diphosphate, sac- 
charose and ethanol from Prolabo; Sephadex LH- 
20 from Pharmacia and Ultrogel AcA34 from IBF. 
2.1.4. Buffers and solutions 
Phosphate-buffered saline (PBS) consisted of 
10 mM potassium phosphate buffer (pH 7.4) and 
0.15 M NaCl supplemented or not with 50 mM 
NaF; Ringer’s solution was from Flow; buffer A 
comprised 10 mM potassium phosphate buffer 
(pH 7.4), 1.5 mM EDTA and 50 mM NaF; buffer 
B consisted of 50 mM potassium phosphate buffer 
and 1.5 mM EDTA; buffer C was composed of 
50 mM Tris (pH 7.4) and 1.5 mM EDTA; buffer 
D comprised 10 mM Tris (pH 7.4), 1 mM CaC12 
and 1 mM MgClz. 
2.2. Methods 
2.2.1. HTC cell culture and cytosol preparation 
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HTC cells are a line of cells established from the 
ascites form of the rat hepatoma Morris 7288~. 
Cells were cultured in suspension (spinner) in 
Swim’s medium (Gibco) buffered by 15 mM 
Tricine (Sigma) and supplemented with 10% 
newborn calf serum [S]. After seeding at 5 x lo4 
cells/ml and regular feeding when the cell concen- 
tration reached 5 x 10’ cells/ml, the cells were col- 
lected at near confluency (B-10 x lo5 cells/ml). 
After centrifugation at 2000 x g for 10 min, the 
cell pellet was washed twice with PBS and stored at 
- 80°C. After cell thawing, Potter homogeniza- 
tion was performed in buffer D and cytosol was 
obtained by ultracentrifugation of the homogenate 
at 220000 x g for 60 min. 
2.2.2. Rat liver cytosol preparation 
Sprague-Dawley male rats were killed by cervical 
dislocation. Livers were perfused in situ with 
Ringer’s solution or PBS, to eliminate the max- 
imum of hemoglobin, and stored at - 196°C. 
After thawing, they were Potter-homogenized in 
buffer A containing 1 mM PMSF, 50pM leupep- 
tin, 50 ,xM TPCK and aprotinin (40 KIU/ml). The 
homogenate was centrifuged at 10000 x g for 
10 min, followed by centrifugation of the superna- 
tant at 70000 x g for 15 min. Cytosol was obtained 
by final ultracentrifugation at 220000 x g for 
60 min and stored in aliquots at - 80°C. 
2.2.3. 25-Hydroxycholesterol-binding assay 
This was performed as described in [5]. Briefly, 
cytosol proteins were precipitated with (NH4)2S04 
at between 25 and 50% saturation for liver and 
25-40% for HTC cells. After dissolution of the 
protein precipitate in buffer B for liver and buffer 
C for HTC cells, proteins were incubated in the 
presence of a saturating concentration (20 nM) of 
25-hydroxy[3H]cholesterol with or without an ex- 
cess of 10v6 M unlabeled sterol for 2 h at 4°C. 
Free sterol excess was cleared by Sephadex LH-20 
gel filtration. The radioactivity of labeled proteins 
eluted in the void volume of the column was 
measured by liquid scintillation counting. Specific 
binding was calculated from the difference be- 
tween total binding (radioactivity eluted after 
labelling in the presence of tritiated sterol alone) 
and nonspecific binding (radioactivity eluted after 
labeling in the presence of an excess of unlabeled 
sterol). In some experiments, an aliquot of the 
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eluate was subjected to ultracentrifugation on a 
linear sucrose density gradient (5-20%). 
2.2.4. Molecular mass determination of the 
25-hydroxy[3H]cholesterol-protein complex 
For HTC cells, a 25-hydroxy[3H]cholesterol- 
protein complex was subjected to chromatography 
on a calibrated Ultrogel AcA34 column (elution 
buffer: buffer C + 0.1 M KCl). For rat liver, whole 
cytosol was layered on a Superose 12 column 
(FPLC system from Pharmacia) and eluted with 
buffer B. The collected fractions were precipitated 
with ammonium sulfate (O-50070 saturation) and 
tested for 25-hydroxy[3H]cholesterol binding. The 
molecular masses were calculated as a function of 
the Stokes radius and sedimentation coefficient of 
the protein as described in [5]. 
3. RESULTS 
3.1. Saturability and sedimentation coefficient of 
the OSBP 
Using experimental conditions reported in [5], a 
protein saturable by 25-hydroxy[3H]cholesterol 
and with a sedimentation coefficient of 8 f 0.2 S 
was demonstrated in the HTC cell model (fig.1). 
The binding site number was about 900 fmol/mg 
protein. 
We had to modify the methodology for rat liver 
cytosol protein, particularly in the steps of liver 
perfusion and cytosol preparation. Fig.2 shows 
that the binding site number increased from 240 to 
420 fmol/mg protein when the liver was perfused 
with PBS + NaF instead of Ringer’s solution 
(fig.2B). The addition of protease inhibitors in 
buffer A (homogenization buffer) led to a sharp 
increase in binding sites (from 420 to 840 fmol/mg 
protein) (fig.2C). The nonspecific binding disap- 
peared almost totally. 
The sedimentation coefficient of the liver 
cytosol protein was about 7.7 rt: 0.2 S. 
3.2. High affinity and stability of the OSBP 
Association of 25-hydroxy[3H]cholesterol with 
the protein was rapid in the first 90 min of incuba- 
tion and then increased slowly up to 180 min. The 
dissociation constant of the 25-hydroxycholes- 
terol-protein complex was determined by 
Scatchard analysis (fig.3). There was only one 
population of binding sites. The & values of HTC 
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Fig. 1. 25-Hydroxy[3H]cholesterol binding to cytosol 
proteins of HTC cells. Binding assay was performed as 
described in section 2. After filtration on Sephadex LH- 
20, an aliquot of the proteins was subjected to 
ultracentrifugation on a linear (5-20%) sucrose 
gradient. (M) Labeling in the presence of 25- 
hydroxy[3H]cholesterol (20nM) alone. (O---O) Label- 
ing in the presence of a 300 nM excess of unlabeled 25- 
hydroxycholesterol. Binding site number: 900 fmol/mg 
protein. 
cell and rat liver OSBPs were very similar: 6.9 x 
10m9 M (maximum binding site number: 
960 fmol/mg protein, 25000 sites/cell) and 9.2 x 
10e9 M (maximum binding site number: 655 + 
180 fmol/mg protein, mean of 3 experiments), 
respectively. 
When the rats were killed at the maximum level 
of cholesterol biosynthetic activity (middle of the 
dark phase), no change in the Kd of the protein was 
observed, but the maximum binding site number 
increased to 1800 fmol/mg protein. The 25- 
hydroxy[3H]cholesterol-protein complex was very 
stable after 24 h at 0°C. The unliganded protein 
was unstable after cytosol storage for 24 h at 0°C. 
By contrast, the 25-50% fraction retained its 
binding capacity when stored for 24 h at 0°C. 
99 
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Fig.2. 25-Hydroxy[3H]cholesterol binding to cytosol proteins of rat liver. Binding assay was performed as described in 
section 2 and the legend to fig. 1. (A) Liver washing without PBS and NaF (240 fmol/mg protein); (B) cytosol 
preparation without protease inhibitors (420 fmol/mg protein); (C) combination of PBS + NaF washing and protease 
inhibitors during cytosol preparation (840 fmol/mg protein). Symbols as in fig. 1. 
3.3. Molecular mass of the complex 
This differed very slightly between the models: 
160600 Da for HTC cells (Rs = 47.5 A) vs 
162400 Da for rat liver OSBP (Rs = 48 A). 
3.4. Specificity of cytosol OSBP 
We compared the relative binding affinities of 
several derivatives of cholesterol oxygenated either 
on the nucleus (C-7) or on the side chain. Fig.4 
shows the competition curves obtained after in- 
cubation of the 25-50070 fraction of rat liver 
cytosol proteins with 20 nM 25-hydroxy[3H]cho- 
lesterol and increasing concentrations (lo-* to 
10F5 M) of unlabeled sterol. No noticeable dif- 
ferences were found when the relative binding af- 
finities of rat liver and HTC cell proteins were 
compared (table 1): both proteins preferentially 
bound the compounds oxygenated on the side 
chain, with a low affinity for the compounds 
oxygenated at C-7. The hepatic protein discrimi- 
nated between the two (R) and (s) epimers of 23- 
hydroxycholesterol and, to a lesser extent, those of 
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24-hydroxycholesterol. 2Ocr-Hydroxycholesterol 
was the best competitor in both models. 26- 
Hydroxycholesterol and 24(R,S),25-epoxycho- 
lesterol were less competitive than 25-hydro- 
xycholesterol and 23(S)-hydroxycholesterol. The 
poor solubility of the A20(22) derivative of 25- 
hydroxycholesterol precluded testing its competi- 
tion as for the other sterols. Nevertheless, it did 
not appear to be recognized by the liver OSBP, 
whereas the A23 derivative was an excellent com- 
petitor, as effective as 25-hydroxycholesterol itself. 
The addition of a hydroxyl function at C-7 
noticeably decreased the affinity of 25-hydroxy- 
cholesterol for the OSBP: 7,25-dihydroxychol- 
ester01 was a very poor competitor, as well as 7~- 
and 7,LLhydroxycholesterol and 7-ketocholesterol 
(IGO in the same range, 6 x 10m6 M). Neither ox- 
idosqualene nor squalene was able to bind OSBP. 
Tested at 10e6 M, the following steroids were not 
recognized: cholesterol, 20-hydroxyecdysone, dex- 
amethasone, estradiol, and hydroxytamoxifen, as 
well as the 25- and 1,25-hydroxylated erivatives 
of vitamin D3 (only studied in HTC cells). 
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Fig.3. Scatchard plot of 25-hydroxy[3H]cholesterol 
binding to the cytosol proteins of HTC cells and rat 
liver. Binding assays were performed, as described in 
section 2, in the presence of increasing concentrations (0 
to 30 nM) of tritiated 25-hydroxycholesterol. Non- 
specific binding was determined with a 10m6 M (rat liver) 
or 3 x lo-’ M (HTC cells) excess of unlabeled 25 
hydroxycholesterol. (A) Rat liver, (B) HTC cells. 
4. DISCUSSION 
The preliminary results obtained by Kandutsch 
and Thompson [2] on 25-hydroxycholesterol 
binding by fetal mouse liver cells were not con- 
vincing since, in the established line FL83B, two 
proteins of respectively 8 S and 5 S sedimentation 
coefficient were able to bind the tritiated 25-hydro- 
xycholesterol but the characters of saturability and 
specificity of the binding were not firmly estab- 
lished. Moreover, in primary cultures of liver cells, 
the 5 S binding was largely predominant. Here we 
have demonstrated that the OSBPs of adult rat 
liver and HTC cell cytosol have physicochemical 
characteristics very similar to those of OSBPs 
demonstrated in L cells [1,2,9], normal human 
lymphocytes [4] and rat embryo fibroblasts [5]: 
sedimentation coefficient about 8 S, high affinity 
(Kd about 5 X 10m9 M), molecular mass of the 
complex (about 160 kDa). 
The characterization of the hepatic protein has 
required some modification of the methodology 
described in [5]: 
(i) The protein appears to be very sensitive to the 
presence of phosphate ions and NaF during cytosol 
preparation, indicating that it may have to be 
phosphorylated to bind its ligand. Nevertheless, 
when the 25-hydroxy[3H]cholesterol-protein com- 
plex or the unliganded protein was treated with 
Fig.4. Competition of several oxygenated sterols with 
tritiated 25-hydroxy[3H]cholesterol in rat liver cytosol. 
alkaline phosphatases from E. coli or calf in- 
testine, neither the quantity of 25-hydroxy[3H]- 
cholesterol bound to the protein nor the sedimen- 
tation coefficient of the complex was modified. 
(ii) The addition of protease inhibitors elimi- 
nated nonspecific binding and increased the 
specific 8 S labeling. These inhibitors were only 
necessary in the steps preceding cytosol protein 
101 
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Table 1 
Relative binding affinities of HTC cell and rat liver OSBPs for several sterols 
Rat liver HTC cells 
1’250 @I) RBA ICJO RBA 
25-OH-chol 5 x 10-S 100 3 x 10-a 100 
23-Dehydro-25-OH-chol 4.5 x 1o-8 111 
20cu-OH-chol 2.1 x lo-’ 23.8 8 x lo-’ 37.5 
26OH-chol lo-” 5 3.4 x lo-’ 8.8 
24,25(R,S)-epoxychol 1.7 x 1o-6 2.9 
23(S)-OH-chol 4 x lo-’ 12.5 
23(R)-OH-chol - 0 
24(R)-OH-chol 8 x lo-’ 6.3 
24(S)-OH-chol 1.8 x 1O-6 2.8 
7-Keto-chol 6 x 1O-6 0.8 2 x 1o-6 1.5 
7&OH-chol 6 x 1O-6 0.8 7 x 1o-6 0.4 
7,25-Dihydroxy-chol 6 x 1O-6 0.8 
7a-OH-chol 9 x 1o-6 0.5 
I&, sterol concentration yielding 50% competition with 20 nM 25-hydroxy[3H]cho- 
lesterol; RBA, binding affinities relative to 25-hydroxycholesterol (100) 
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precipitation by ammonium sulfate. The 5 S 
binding protein in liver cell cultures [2] could be ex- 
plained by the absence of protease inhibitors in the 
experiments. 
Contrary to a classical steroid hormone recep- 
tor, the 8 S sedimentation coefficient of the com- 
plex did not change in a high-ionic-strength buffer 
or with a temperature increase (20°C for 120 min), 
indicating that there was no ‘activation’ of the pro- 
tein. 
The relative binding affinities were determined 
for 2 groups of oxysterols: 7-oxygenated sterols 
and side-chain-oxygenated sterols. With respect o 
the sterols tested in both models (rat liver and HTC 
cells), similar results were obtained: ‘I-oxygenated 
derivatives were weakly recognized contrary to the 
cholesterol derivatives hydroxylated on the side 
chain. Not only the presence of a hydroxyl func- 
tion on the side chain was important for sterol af- 
finity but also the localization and spatial con- 
figuration of the function: 
(i) The most competitive sterols were, in decreas- 
ing order: 25-OH > 20~OH > 23(S)-OH > 24(R)- 
OH > 26-OH. 
(ii) Amongst the two (R) and (5) epimers of 23- 
hydroxycholesterol, only the (s) epimer was 
recognized by OSBP; 24(R)-hydroxycholesterol 
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had a better affinity than its 24(s) epimer. 
Desaturation of the side chain in position 23 did 
not change the affinity of 25-hydroxycholesterol. 
Desaturation in position 20(22) reduced the sterol 
solubility and did not allow extensive competition 
experiments. 
Rat liver OSBP was also able to bind 24(R,s)- 
epoxycholesterol; the 24(s) epimer was recently 
described by Saucier et al. [lo] as a possible en- 
dogenous sterol regulating cholesterol biosyn- 
thesis. Unfortunately, we were unable to use the 
pure 24(s) and 24(R) epimers, which could explain 
the relatively low relative binding affinity of the 
mixture. 
The modification of the nucleus of 25 
hydroxycholesterol (addition of a hydroxyl func- 
tion on C-7, or acetylation of the 3,&hydroxyl 
function) prevented the binding of 25- 
hydroxycholesterol to OSBP. Nevertheless, Taylor 
et al. [6] report that the 3fi,25-dihydroxycholest-5- 
en-7-one has a great affinity for the L cell OSBP. 
Sterol carrier proteins (SCPs) are major 
regulators of lipid metabolism and transport, and 
have been described in liver and adrenals. SCPr 
[l l] stimulates the conversion of squalene to 
lanosterol, whereas SCPZ [12,13] (or FABP) ac- 
tivates the conversion of lanosterol into 
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cholesterol. In order to differentiate the hepatic 
OSBP from SCPs, we tested its affinity for 
squalene and oxidosqualene. Neither compound 
was bound by rat liver or HTC cell OSBP. 
Although SCP2 appears to be able to bind 25 
hydroxycholesterol [ 141, the differences between 
the molecular masses of SCPs (12-18 kDa) and 
OSBP clearly exclude a similarity between the pro- 
teins. Circadian variations of SCP2 have been 
described [15], with an increase ( x 7) in the dark 
period. Preliminary experiments with hepatic 
OSBP show similar results, i.e. an increase (x 3) 
of the binding site number without Kd modifica- 
tion in the dark period. 
The biological role of the OSBP has not been 
firmly demonstrated. The main hypothesis is that 
the protein is a regulator of sterol biosynthesis, ac- 
ting at the level of HMG-CoA reductase. Taylor et 
al. [6] have in fact demonstrated a correlation in L 
cells between the capacity of oxysterols to inhibit 
HMG-CoA reductase and their capacity to bind 
OSBP. This hypothesis cannot be excluded in a 
strong cholesterogenic organ such as the liver, and 
OSBP could be another regulatory protein in the 
sterol metabolism of liver. The low affinity of 
OSBP for cholesterol derivatives oxygenated on C- 
7 seems to exclude that 7a-hydroxycholesterol, 
classically described as the first intermediary com- 
pound in biliary acid synthesis, could be involved 
in liver HMG-CoA reductase regulation. 
A loss of feedback control of HMG-CoA reduc- 
tase by exogenous cholesterol has been described in 
hepatomas [16]. Nevertheless, recent works on 
sterol synthesis regulation in HTC cells 
demonstrate that the intracellular mechanism of 
cholesterol synthesis regulation by lipoproteins is 
intact in these cells [17] and that the phosphor- 
ylation-dephosphorylation mechanism of the re- 
ductase is functional [18]. It is thus not surprising 
that no difference was found between normal rat 
liver and cancerous liver OSBP. 
In conclusion, rat liver seems to be a good model 
for OSBP purification since the physicochemical 
characters of the hepatic protein are comparable to 
those of OSBP found in cell cultures. 
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